WHO approves Pfizer's coronavirus vaccine for emergency use
Pfizer reaches deal to supply US with 100M additional vaccine doses Dr. Prem Premsrirut of SUNY Downstate Medical Center joins […]
» Read moreAllergic reactions to vaccines are generally rare and people with common allergies are not more likely to have a reaction […] Nearly a quarter of the world’s population may not have access to a COVID-19 vaccine until at least 2022, warns […] AstraZeneca will test a combination of its coronavirus vaccine and Russia’s Sputnik V shot in the hopes it will make […] The full results of a clinical trial for the Pfizer-BioNTech COVID-19 vaccine were published in the New England Journal of […] An EU regulator considering the rapid approval of coronavirus vaccines said Wednesday it had been the target of a cyberattack, […] New York is expected to receive its first doses of the coronavirus vaccine as early as this weekend, Governor Andrew […] Chinese pharmaceutical firm Sinovac Biotech has secured half a billion dollars in extra funding to produce its COVID-19 vaccine, it […] Health care workers, care home residents first in line for COVID vaccine CDC advisory panel votes on priority for phase […] The British government on Friday said it has asked its independent medicines regulator to study Pfizer/BioNTech’s coronavirus vaccine with a […]
ACAAI: Reaction to COVID-19 vaccine unlikely for those with common allergies
Much of the world may not have access to a COVID-19 vaccine until 2022
AstraZeneca will test combination of its covid vaccine and Russia's
Pfizer vaccine results published in peer-reviewed journal
Cyberattack hits EU vaccine regulator as West grapples with virus surge
New York expects first vaccine doses within days
Chinese COVID-19 vaccine maker gets $500 million funding boost
Live Updates: Health care workers and nursing home residents should get first vaccine, US panel says
UK asks regulator to assess Pfizer/BioNTech vaccine
